Sullumab
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Sullumab, covering 2026-03-23 to 2026-03-23. Get the full timeline:
Most recent: Clinical Trial Update: Comparing the Combination of Sullumab and Fruquintinib in Postoperative Adjuvant Therapy for High Recurrence Risk Non Transparent Renal Cell Carcinoma [Phase 2]